Agent containing flavonoid derivatives for treating cancer and inflammation

US9687469B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9687469-B2
Application numberUS-201514835198-A
CountryUS
Kind codeB2
Filing dateAug 25, 2015
Priority dateNov 26, 2014
Publication dateJun 27, 2017
Grant dateJun 27, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A pharmaceutical composition for the prevention and treatment of cancer with specific flavanoid-based compounds selected from among the groups of Flavone, Flavanone and Flavanol, a method for the prevention and treatment of cancer and inflammation using the specific flavonoid-based pharmaceutical compositions, a method for isolating the flavonoid-based pharmaceutical compositions from raw plant material, and a method for synthesizing said specific flavonoid-based pharmaceutical compositions.

First claim

Opening claim text (preview).

We claim: 1. A flavonoid-based pharmaceutical composition for the selected from the group consisting of brain cancer, breast cancer, colon cancer, Kaposi sarcoma, leukemia, lung cancer, melanoma, oral and laryngeal cancer, ovarian cancer, pancreatic cancer, prostate cancer, stomach cancer, and thyroid cancer treatment of cancer and/or inflammation having a flavanone chemical structure of chemical formula 4: or any pharmaceutically acceptable salt thereof; wherein the group R1 may be an alkoxy group (O—CH3) a methoxy group (H3CO) or hydrogen, the groups R2 and R3 may each be a methoxy group (H3CO) or a hydroxy group (HO), the group R4 may be hydrogen, the groups R5, R7 and R10 are nothing, the group R6 may be an alkoxy group (O—CH3), a hydroxyl group (OH) or hydrogen, the group R8 may be an alkoxy group (O—CH3) or hydrogen, the group R9 may be a hydroxyl group (OH), halogen bromine (Br), chlorine (Cl), flourine (F), hydroxamic acid group (O2NH2HCl), amine (NH2), amide (R2N), or hydrogen; and wherein A and B may each be selected from the group consisting of: a single bond and a double bond.

Assignees

Inventors

Classifications

  • with aryl radicals attached in position 2 · CPC title

  • A61K31/353Primary

    3,4-Dihydrobenzopyrans, e.g. chroman, catechin · CPC title

  • 2,3-Dihydro derivatives, e.g. flavanones · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9687469B2 cover?
A pharmaceutical composition for the prevention and treatment of cancer with specific flavanoid-based compounds selected from among the groups of Flavone, Flavanone and Flavanol, a method for the prevention and treatment of cancer and inflammation using the specific flavonoid-based pharmaceutical compositions, a method for isolating the flavonoid-based pharmaceutical compositions from raw plant…
Who is the assignee on this patent?
Lowe Henry, Toyang Ngeh J, Bryant Joseph, and 2 more
What technology area does this patent fall under?
Primary CPC classification A61K31/353. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).